Evidence map›Paper›PMID 39319067›Full record

ArticleFrontiers in psychology2024

Validation of behavioral measures of social cognition in individuals diagnosed with schizophrenia.

Noa Rahamim, Reut Gilad, Omer Linkovski, Hagai Bergman, Keren Avirame, Yasmin Abo Foul, Renana Eitan

Abstract read
In one paragraph

Article in Frontiers in psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Noa RahamimThe Edmond and Lily Safra Center for Brain Science, Hebrew University, Jerusalem, Israel.
Reut GiladPsychiatric Division, Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv, Israel.
Omer LinkovskiThe Jerusalem Mental Health Center, Jerusalem, Israel.
Hagai BergmanThe Edmond and Lily Safra Center for Brain Science, Hebrew University, Jerusalem, Israel.
Keren AviramePsychiatric Division, Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv, Israel.
Yasmin Abo FoulPsychiatric Division, Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv, Israel.
Renana EitanPsychiatric Division, Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia, a complex neuropsychiatric disorder, manifests severe impairments in social cognition, notably in Theory of Mind (ToM), empathy, and emotion recognition, which significantly influence social competence and overall functioning. These aspects are crucial for prognosis in individuals diagnosed with schizophrenia (SZ). This study validates a comics strip paradigm for ToM and empathy assessment, the Montreal Affective Voices (MAV) for measuring emotion recognition, and a Go-NoGo task for inhibition control estimation in individuals diagnosed with SZ, comparing their performance with healthy controls. SZ participants exhibited diminished abilities in the comics strip task, especially in ToM and empathy conditions, alongside challenges in identifying emotions from vocal cues in MAV. They responded slower and tended to be less accurate in the Go-NoGo task. The validated behavioral battery addresses the limitations of previous measures and emerges as a promising tool for future investigations into the neural systems underlying social cognition in schizophrenia. Such insights can lead to the development of long-needed treatment for negative symptoms and social dysfunctions in schizophrenia.

Indexed as

comic stripemotion recognitionGo-NoGoMontreal Affective Voices (MAV)schizophreniasocial cognitiontheory of mind (ToM)

Identifiers

PMID39319067
PMCPMC11420990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.